loading page

The role of CD8 + T-cells in colorectal cancer immunotherapy
  • +7
  • Tao He,
  • Chencheng Hu,
  • Shichao Li,
  • Yao Fan,
  • Fei Xie,
  • Xin Sun,
  • Qingfeng Jiang,
  • Weidong Chen,
  • Yingtian Jia,
  • Wusheng Li
Tao He
The Affiliated Hospital of Traditional Chinese Medicine of Southwest Medical University
Author Profile
Chencheng Hu
The Affiliated Hospital of Traditional Chinese Medicine of Southwest Medical University
Author Profile
Shichao Li
The Affiliated Hospital of Traditional Chinese Medicine of Southwest Medical University
Author Profile
Yao Fan
The Affiliated Hospital of Traditional Chinese Medicine of Southwest Medical University
Author Profile
Fei Xie
The Affiliated Hospital of Traditional Chinese Medicine of Southwest Medical University
Author Profile
Xin Sun
The Affiliated Hospital of Traditional Chinese Medicine of Southwest Medical University
Author Profile
Qingfeng Jiang
The Affiliated Hospital of Traditional Chinese Medicine of Southwest Medical University
Author Profile
Weidong Chen
The Affiliated Hospital of Traditional Chinese Medicine of Southwest Medical University
Author Profile
Yingtian Jia
The Affiliated Hospital of Traditional Chinese Medicine of Southwest Medical University
Author Profile
Wusheng Li
The Affiliated Hospital of Traditional Chinese Medicine of Southwest Medical University

Corresponding Author:[email protected]

Author Profile

Abstract

:Immunotherapy has been an advanced and effective approach to treating various types of solid tumors in recent years, and the most successful strategy is immune checkpoint inhibitors (ICIs), which have shown beneficial effects in patients with colorectal cancer (CRC). Drug resistance to ICIs is usually associated with CD8 + T-cells targeting tumor antigens; thus, CD8 + T-cells play an important role in immunotherapy. Unfortunately, Under continuous antigen stimulation, tumor microenvironment(TME), hypoxia and other problems it leads to insufficient infiltration of CD8 + T-cells, low efficacy and mechanism exhaustion, which have become obstacles to immunotherapy. Thus, this article describes the relationship between CRC and the immune system, focuses on the process of CD8 + T-cells production, activation, transport, killing, and exhaustion, and expounds on related mechanisms leading to CD8 + T-cells exhaustion. Finally, this article summarizes the latest strategies and methods in recent years, focusing on improving the infiltration, efficacy, and exhaustion of CD8 + T-cells, which may help to overcome the barriers to immunotherapy.